Bryja V - Search Results

1

Molecular pathology of the fibroblast growth factor family.

Krejci P, Prochazkova J, Bryja V, Kozubik A, Wilcox WR. Krejci P, et al. Among authors: bryja v. Hum Mutat. 2009 Sep;30(9):1245-55. doi: 10.1002/humu.21067. Hum Mutat. 2009. PMID: 19621416 Free PMC article. Review.

2

Sex differences and risk factors for bleeding in Alagille syndrome.

Hankeova S, Van Hul N, Laznovsky J, Verboven E, Mangold K, Hensens N, Adori C, Verhoef E, Zikmund T, Dawit F, Kavkova M, Salplachta J, Sjöqvist M, Johansson BR, Hassan MG, Fredriksson L, Baumgärtel K, Bryja V, Lendahl U, Jheon A, Alten F, Fahnehjelm KT, Fischler B, Kaiser J, Andersson ER. Hankeova S, et al. Among authors: bryja v. EMBO Mol Med. 2022 Dec 7;14(12):e15809. doi: 10.15252/emmm.202215809. Epub 2022 Nov 8. EMBO Mol Med. 2022. PMID: 36345711 Free PMC article.

3

Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity.

Němec V, Khirsariya P, Janovská P, Moyano PM, Maier L, Procházková P, Kebková P, Gybel' T, Berger BT, Chaikuad A, Reinecke M, Kuster B, Knapp S, Bryja V, Paruch K. Němec V, et al. Among authors: bryja v. Angew Chem Int Ed Engl. 2023 Mar 6;62(11):e202217532. doi: 10.1002/anie.202217532. Epub 2023 Feb 2. Angew Chem Int Ed Engl. 2023. PMID: 36625768

4

Conditions for gene transfection into the HL-60 human leukaemia cell line by electroporation.

Pacherník J, Janík R, Hofmanová J, Bryja V, Kozubík A. Pacherník J, et al. Among authors: bryja v. Folia Biol (Praha). 2002;48(4):154-6. Folia Biol (Praha). 2002. PMID: 12194203

5

Early cycling-independent changes to p27, cyclin D2, and cyclin D3 in differentiating mouse embryonal carcinoma cells.

Preclíková H, Bryja V, Pacherník J, Krejcí P, Dvorák P, Hampl A. Preclíková H, et al. Among authors: bryja v. Cell Growth Differ. 2002 Sep;13(9):421-30. Cell Growth Differ. 2002. PMID: 12354751

6

Lipoxygenase inhibitors enhance tumor suppressive effects of jun proteins on v-myb-transformed monoblasts BM2.

Bryja V, Sedlácek J, Zahradnícková E, Sevcíková S, Pacherník J, Soucek K, Hofmanová J, Kozubík A, Smarda J. Bryja V, et al. Prostaglandins Other Lipid Mediat. 2003 Nov;72(3-4):131-45. doi: 10.1016/s1098-8823(03)00052-2. Prostaglandins Other Lipid Mediat. 2003. PMID: 14674625

7

The role of p27(Kip1) in maintaining the levels of D-type cyclins in vivo.

Bryja V, Pacherník J, Faldíková L, Krejcí P, Pogue R, Nevrivá I, Dvorák P, Hampl A. Bryja V, et al. Biochim Biophys Acta. 2004 May 3;1691(2-3):105-16. doi: 10.1016/j.bbamcr.2004.01.001. Biochim Biophys Acta. 2004. PMID: 15110991 Free article.

8

FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells.

Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, Wilcox WR. Krejci P, et al. Among authors: bryja v. Exp Cell Res. 2004 Jul 1;297(1):152-64. doi: 10.1016/j.yexcr.2004.03.011. Exp Cell Res. 2004. PMID: 15194433

9

Aryl hydrocarbon receptor-activating polychlorinated biphenyls and their hydroxylated metabolites induce cell proliferation in contact-inhibited rat liver epithelial cells.

Vondrácek J, Machala M, Bryja V, Chramostová K, Krcmár P, Dietrich C, Hampl A, Kozubík A. Vondrácek J, et al. Among authors: bryja v. Toxicol Sci. 2005 Jan;83(1):53-63. doi: 10.1093/toxsci/kfi009. Epub 2004 Oct 13. Toxicol Sci. 2005. PMID: 15483185

10

c-Jun induces apoptosis of starved BM2 monoblasts by activating cyclin A-CDK2.

Vanhara P, Bryja V, Horváth V, Kozubík A, Hampl A, Smarda J. Vanhara P, et al. Among authors: bryja v. Biochem Biophys Res Commun. 2007 Feb 2;353(1):92-7. doi: 10.1016/j.bbrc.2006.11.124. Epub 2006 Dec 4. Biochem Biophys Res Commun. 2007. PMID: 17173865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

145 results

Search Page

Filters